The estimated Net Worth of William Montrose Investment... is at least $5.43 Million dollars as of 8 November 2019. William Investment owns over 9,591 units of Reata Pharmaceuticals Inc stock worth over $3,411,866 and over the last 5 years William sold RETA stock worth over $2,022,838.
William has made over 1 trades of the Reata Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently William sold 9,591 units of RETA stock worth $2,022,838 on 8 November 2019.
The largest trade William's ever made was selling 9,591 units of Reata Pharmaceuticals Inc stock on 8 November 2019 worth over $2,022,838. On average, William trades about 9,591 units every 0 days since 2019. As of 8 November 2019 William still owns at least 19,795 units of Reata Pharmaceuticals Inc stock.
You can see the complete history of William Investment stock trades at the bottom of the page.
Over the last 8 years, insiders at Reata Pharmaceuticals Inc have traded over $176,850,875 worth of Reata Pharmaceuticals Inc stock and bought 8,443,489 units worth $179,313,590 . The most active insiders traders include Holdings A/S Novo, R Kent Jr Mc Gaughy, and Inc Cpmg. On average, Reata Pharmaceuticals Inc executives and independent directors trade stock every 16 days with the average trade being worth of $10,950,893. The most recent stock trade was executed by Andrea Loewen on 14 September 2023, trading 3,175 units of RETA stock currently worth $546,195.
reata pharmaceuticals, inc. (nasdaq:reta) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
Reata Pharmaceuticals Inc executives and other stock owners filed with the SEC include: